Healthcare DIVE July 15, 2024
Lawmakers said the final rule carries “the risk of greatly altering the United States’ laboratory testing infrastructure.”
Lawmakers have told the Food and Drug Administration to suspend efforts to implement its final rule on laboratory developed tests (LDTs).
The House Appropriations Committee made the request Wednesday in legislation about funding the FDA and other federal agencies will receive in its 2025 financial year. Committee members backed the appropriations bill by a 29-26 vote.
As well as agreeing to provide the FDA with $3.5 billion in direct appropriations, the lawmakers shared advice on how the agency should use the money. The recommendations include a call to suspend work on the final rule and partner with Congress to modernize the regulation...
Today's Sponsors
Today's Sponsor